Thank you to Dr. Fedor Panov and Dr. Patrick Landazuri for leading an incredible conversation on how the latest technologies and clinical practices can transform #epilepsy care. 🧠
It was a PACKED house with great discussion from the attendees. #AES2022
Thanks @NeuroPace@zimmerbiomet for hosting today's breakfast seminar at #assfn2022 and supporting @ASSFNeurosurg dialogue about paradigm shifts in epilepsy surgery.
Here are two of the figures I presented (updated from https://t.co/BkdEzUstpm) for anyone who finds them useful.
A few months ago, it felt like I kept hearing about ⚡️brain stimulation…for depression, addiction, OCD, pain — scientists across the country were trying to treat all kinds of disorders by zapping people’s brains.
Inside the brain stim boom:
https://t.co/ULJ5jNm1XM
Welcome to the @Nasdaq family, @NeuroPace! 🎉
Based in Mountain View, CA, NeuroPace is a medical device company focused on transforming the lives of people suffering from epilepsy.
#NasdaqListed $NPCE rings today's Closing Bell in celebration of the recent listing.
Today we celebrate our listing with @Nasdaq! NeuroPace is now a publicly traded company! We look forward to what the future holds for NeuroPace and the epilepsy community as we continue to transform the lives of people living with #epilepsy. $NPCE
Today is #SUDEPActionDay2020. To all providers who care 4 patients with #epilepsy. Talk about #SUDEP. People with #epilepsy and caregivers want this important education. Knowledge is power.
Personal stories are what makes neurotech come alive.
Here is one published in the NY Daily News about Tracey Drake's journey from seizures controlling her life to her taking control with the NeuroPace RNS device.
https://t.co/92och0rS2i
@WSJhealth Thank you for recognizing @NeuroPace today; with the only FDA-approved medical device that utilizes brain-computer interface technology to treat refractory focal #epilepsy#WSJTECHHEALTH
We are excited to be part of the first @WSJ Health Technology Conference. NeuroPace Chief Medical Officer Martha Morrell, MD, will be interviewed by WSJ Digital Science Editor @danielas_bot on the topic of Treating Neurological Diseases with Brain Interfaces #WSJTechHealth